Your browser doesn't support javascript.
loading
Comparison of intrathecal fentanyl and nalbuphine: a prospective randomized controlled study in patients undergoing total abdominal hysterectomy
Anaesthesia, Pain and Intensive Care. 2017; 21 (2): 194-198
in English | IMEMR | ID: emr-189146
ABSTRACT

Objectives:

0.5% bupivacaine used in subarachnoid block provides only about 3 hours of analgesia. Opioids especially morphine and fentanyl are used as adjuvants to produce extended postoperative analgesia. Nalbuphine is an agonist antagonist and does not require a narcotic license, which is a must for procuring other opioids, so is easily available even in peripheral hospitals. This study was carried out to evaluate the efficacy of nalbuphine versus fentanyl as intrathecal adjuvant
Subject(s)
Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Injections, Spinal / Prospective Studies / Hysterectomy / Adjuvants, Anesthesia / Nalbuphine Type of study: Controlled clinical trial Limits: Adult / Aged / Female / Humans Language: English Journal: Anaesth. Pain Intensive Care Year: 2017

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Injections, Spinal / Prospective Studies / Hysterectomy / Adjuvants, Anesthesia / Nalbuphine Type of study: Controlled clinical trial Limits: Adult / Aged / Female / Humans Language: English Journal: Anaesth. Pain Intensive Care Year: 2017